Regulatory and health technology assessment of cell and gene therapies in Europe: Convergence or divergence?

被引：0
|
作者：
Hoogendoorn, Mark [1 ]
Fabriek, Babs [2 ]
Bloem, Lourens T. [1 ]
机构：
[1] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands
[2] Dutch Med Evaluat Board, Utrecht, Netherlands
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
61
引用
收藏
页码：16 / 16
页数：1
相关论文
共 50 条
  • [31] Governing Science and Technology Under the International Economic Order: Regulatory Divergence and Convergence in the Age of Megaregionals
    Burri, Mira
    ASIAN JOURNAL OF INTERNATIONAL LAW, 2020, 10 (02) : 411 - 411
  • [32] Governing Science and Technology under the International Economic Order: Regulatory Divergence and Convergence in the Age of Megaregionals
    Qian, Xu
    MANCHESTER JOURNAL OF INTERNATIONAL ECONOMIC LAW, 2023, 20 (03): : 492 - 494
  • [33] Governing Science and Technology under the International Economic Order: Regulatory Divergence and Convergence in the Age of Megaregionals
    Gosain, Ashish
    JOURNAL OF SCIENTOMETRIC RESEARCH, 2019, 8 (01) : 54 - 61
  • [34] Health Technology Assessment and Appraisal of Therapies for Rare Diseases
    Iskrov, Georgi
    Miteva-Katrandzhieva, Tsonka
    Stefanov, Rumen
    RARE DISEASES EPIDEMIOLOGY: UPDATE AND OVERVIEW, 2ND EDITION, 2017, 1031 : 221 - 231
  • [35] HEALTH TECHNOLOGY ASSESSMENT OF HIGH-VALUE THERAPIES
    Hegyi, R.
    Toth, E.
    Ersek, K.
    Nagy, B.
    VALUE IN HEALTH, 2013, 16 (07) : A491 - A491
  • [36] Regulatory Pathways for Cell and Gene Therapies: Balancing Innovation with Compliance
    Bernard, Claire
    Journal of Commercial Biotechnology, 2024, 29 (06): : 136 - 144
  • [37] HEALTH TECHNOLOGY ASSESSMENT FOR CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPIES FOR CANCER
    Hollier-Hann, G.
    Brown, A.
    Ralston, S.
    Curry, A.
    Cork, D.
    VALUE IN HEALTH, 2018, 21 : S65 - S65
  • [38] Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe
    Vreman, Rick A.
    Naci, Huseyin
    Goettsch, Wim G.
    Mantel-Teeuwisse, Aukje K.
    Schneeweiss, Sebastian G.
    Leufkens, Hubert G. M.
    Kesselheim, Aaron S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (02) : 350 - 357
  • [39] Health technology assessment in Europe - Improving clarity and performance
    Cookson, R
    Maynard, A
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2000, 16 (02) : 639 - 650
  • [40] Variation in Health Technology Assessment and Reimbursement Processes in Europe
    Akehurst, Ronald L.
    Abadie, Eric
    Renaudin, Noel
    Sarkozy, Francois
    VALUE IN HEALTH, 2017, 20 (01) : 67 - 76
12345